Acceleration of autoimmunity by organochlorine pesticides in (NZB x NZW)F1 mice.
Systemic lupus erythematosus (SLE) is an autoimmune disorder that affects women more frequently than men. In the (NZB times NZW)F1 mouse, a murine SLE model, the presence or absence of estrogen markedly influences the rate of progression of disease. Three organochlorine pesticides with estrogenic effects were administered chronically to ovariectomized female (NZB times NZW)F1 mice, and we measured the time to development of renal disease, the principal clinical manifestation of lupus in this model. Treatment with chlordecone, methoxychlor, or o,p -dichlorodiphenyltrichloroethane (o,p -DDT) significantly decreased the time to onset of renal impairment, as did treatment with 17ss-estradiol used as a positive control. In an expanded study of chlordecone, we found a dose-related early appearance of elevated anti-double-strand DNA autoantibody titers that corresponded with subsequent development of glomerulonephritis. Immunohistofluorescence confirmed early deposition of immune complexes in kidneys of mice treated with chlordecone. These observations are consistent with an effect of these organochlorine pesticides to accelerate the natural course of SLE in the (NZB times NZW)F1 mouse. Although we originally hypothesized that the effect on progression of autoimmunity was due to estrogenic properties of the pesticides, autoimmune effects and estrogenicity, assessed through measurement of uterine hypertrophy, were not well correlated. This may indicate that uterine hypertrophy is a poor indicator of comparative estrogenic effects of organochlorine pesticides on the immune system, or that the pesticides are influencing autoimmunity through a mode of action unrelated to their estrogenicity.
Sobel
Eric S
ES
Department of Medicine, University of Florida College of Medicine, Gainesville, Florida, USA. sobeles@medicine.ufl.edu
Gianini
John
J
Butfiloski
Edward J
EJ
Croker
Byron P
BP
Schiffenbauer
Joel
J
Roberts
Stephen M
SM
D000818:Animals; D015551:Autoimmunity / Q000187:drug effects*; D007631:Chlordecone / Q000633:toxicity*; D003634:DDT / Q000633:toxicity*; D004195:Disease Models, Animal; D004968:Estrogens, Non-Steroidal / Q000633:toxicity*; D005260:Female; D007306:Insecticides / Q000633:toxicity*; D007674:Kidney Diseases / Q000139:chemically induced* / Q000662:veterinary; D008177:Lupus Vulgaris / Q000139:chemically induced / Q000662:veterinary; D008731:Methoxychlor / Q000633:toxicity*; D051379:Mice; D008814:Mice, Inbred NZB; D010052:Ovariectomy / Q000662:veterinary; D011960:Receptors, Estrogen / Q000187:drug effects* / Q000502:physiology*
D004968:Estrogens, Non-Steroidal; D007306:Insecticides; D011960:Receptors, Estrogen; D003634:DDT; C016340:o,p'-DDT; D007631:Chlordecone; D008731:Methoxychlor
Crit Care Med. 1996 Jun;24(6):981-4
8681602
Environ Health Perspect. 2003 Dec;111(16):1883-7
14644661
Crit Rev Toxicol. 1997 Jul;27(4):367-79
9263644
Exp Toxicol Pathol. 1997 Dec;49(6):483-5
9495650
Endocrinology. 1998 Jun;139(6):2905-15
9607801
Br J Rheumatol. 1998 Sep;37(9):1008-10
9783768
Environ Health Perspect. 1999 Oct;107 Suppl 5:737-42
10502539
Toxicol Lett. 2000 Mar 15;112-113:421-32
10720762
Immunity. 2001 Sep;15(3):397-408
11567630
Toxicol Appl Pharmacol. 2002 Feb 15;179(1):1-12
11884232
J Clin Invest. 2002 Jun;109(12):1625-33
12070310
J Exp Med. 1978 Jun 1;147(6):1568-83
308087
J Clin Invest. 1979 May;63(5):902-11
447833
Environ Health Perspect. 1994 Apr;102(4):380-3
7925178
Semin Arthritis Rheum. 1995 Apr;24(5):323-58
7604300
Clin Exp Rheumatol. 1995 Mar-Apr;13(2):217-26
7656468
Int J Fertil Menopausal Stud. 1996 Mar-Apr;41(2):156-65
8829695
Arthritis Rheum. 1997 May;40(5):804-8
9153539